Table 1.
Demographic characteristics of study subjects.
| PLACEBO | CITALOPRAM | Total | P-Value | ||
|---|---|---|---|---|---|
| N=27 | N=27 | ||||
|
Age in years Mean (SD) [range] |
51 (14) [30-75] |
53 (15) [27-75] |
-- | 0.60 | |
| Gender | Women | 23 (85%) | 21 (78%) | 44 (81%) | 0.73 |
| Men | 4 (15%) | 6 (22%) | 10 (19%) | ||
| Race | Caucasian | 23 (85%) | 22 (82%) | 45 (83%) | 0.083 |
|
African American |
4 (15%) | 1 (4%) | 5 (9%) | ||
| Asian | 0 (0%) | 4 (15%) | 4 (7%) | ||
| Ethnicity |
Hispanic or Latino |
3 (11%) | 6 (22%) | 9 (17%) | 0.47 |
|
Not Hispanic or Latino |
24 (89%) | 21 (78%) | 45 (83%) | ||
| IBS Subgroup | Constipation | 11 (41%) | 10 (37%) | 21 (39%) | 1.00 |
| Diarrhea | 11 (41%) | 12 (44%) | 23 (43%) | ||
| Alternator | 5 (19%) | 5 (19%) | 10 (19%) | ||
|
Beck Depression Inventory Score Mean (SD) |
5.9 (5.4) | 6.6 (5.1) | -- | 0.47 | |
|
Discontinued Treatment |
No | 25 (93%) | 20 (74%) | 45 (83%) | 0.14 |
| Yes | 2 (7%) | 7 (26%) | 9 (17%) |